GRAIL, Inc. (GRAL)
61.65
-1.27
(-2.02%)
USD |
NASDAQ |
May 08, 16:00
62.80
+1.15
(+1.87%)
After-Hours: 20:00
GRAIL Research and Development Expense (Annual) : 185.38M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Veracyte, Inc. | 69.17M |
| Insight Molecular Diagnostics, Inc. | 14.66M |
| Exagen, Inc. | 6.254M |
| bioAffinity Technologies, Inc. | 2.089M |
| Biodesix, Inc. | 12.00M |